• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
IntelGenx Technologies Corp. (Form: 8-K, Received
IntelGenx Technologies Corp. (Form: 8-K, Received

... The Company has begun preparation for a phase II-a proof-of-concept (POC) study. Patient enrolment for this study is expected to commence in Q1/2017. The Company expects the results from the study to be available in Q4/2017. Based on the outcome of this first efficacy trial in humans, IntelGenx will ...
11.02 Community Acquired Pneumonia
11.02 Community Acquired Pneumonia

... ▪ Newer macrolides (clarithromycin, azithromycin) have a better coverage of H. influenzae. But there are wide spread resistance among the common Gram-positive bacteria including MSSA, Pneumococcus, Group A Streptococcus. ▪ not be used as single empirical treatment of CAP and soft tissue infections t ...
ALS Drug Guide
ALS Drug Guide

... accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the author and publisher does not warrant that the information in this document is accurate or complete, nor is the author re ...
Psychopharmacology Training
Psychopharmacology Training

... actions on receptors and enzymes, ADs eventually cause a desensitization of key NT receptors in a time course consistent with the delayed onset of AD action of these drugs. Delayed actions of ADs may not only explain the delay in onset of therapeutic action of ADs; they may also explain why some pat ...
lec#9 done by Dareen Mashaqbeh
lec#9 done by Dareen Mashaqbeh

... release histamine and it reaches the blood stream we cannot avoid allergic reactions except by using specific antagonist . -prophylaxis a term used when someone has an allergy towards something and stars taking drugs two months before to avoid allergic reactions . *could a receptor produce a respons ...
Keolax Prescribing Information
Keolax Prescribing Information

... may be impaired in individuals who are particularly sensitive to the effects of Clobazam or in patients taking high doses of the drug. Clobazam should be used in reduced doses in patients with impaired renal or hepatic function. Side Effects Keolax is generally well tolerated. Side effects such as d ...
Osmoprep - Columbia Endoscopy Center
Osmoprep - Columbia Endoscopy Center

... intravenously (in the vein) for sedation and pain control. The medication will produce relaxation and relieve pain. In the case of allergy to the medication, others will be considered. Colonoscopy is a safe procedure. However, it is not risk free. On rare occasion complications do occur. Complicatio ...
Drugs in Common Use for Learning Disabled People
Drugs in Common Use for Learning Disabled People

... for adults. It may not last long enough in the body. The advantages are that it is not given rectally, it acts quickly and only a small amount (10mg in 1 ml) is needed. SUDEP (Sudden Unexpected Death in Epilepsy): This is a worrying syndrome. It appears to happen about 20 minutes after the patient r ...
Pharmacokinetics in the critically ill adult patient: Associate Clinical Professor
Pharmacokinetics in the critically ill adult patient: Associate Clinical Professor

... • Interval/when to check levels: • Start with q24h, but after 1 st dose check a 10-hr level to determine if q24h will work • What you order: • Tobramycin 520 mg IV Q24, check random level 10 hrs after first dose. ...
Preclinical studies of anti-staphylococcal ectolysin
Preclinical studies of anti-staphylococcal ectolysin

... Methods: Characterization of hypersensitivity reactions and immune response Healthy female Wistar albino rats (8-9 weeks old) were administered a single dose of P128 (0.6, 6.0 or 12.0 mg/kg) or were given the same doses (0.6 or 6.0 mg/kg) daily for 7 days. The animals were re-exposed to the same dos ...
UCLH guidelines on angiotensin ii receptor blockers (arbs)
UCLH guidelines on angiotensin ii receptor blockers (arbs)

... The evidence for all ARBs in heart failure is robust, including evidence for losartan. The effect of ARBs in heart failure is a class effect. There are no head-to-head studies indicating superiority or inferiority of one agent over another. Also, losartan is the only ARB where high dose has been sho ...
CARDIAC TOXICITY OF CANCER THERAPEUTIC AGENTS
CARDIAC TOXICITY OF CANCER THERAPEUTIC AGENTS

... solid tumors (breast, SCLC) . • Acute toxicity : arrhythmias, LV dysfunction, and ...
highlights of prescribing information
highlights of prescribing information

... These highlights do not include all the information needed to use CLARINEX safely and effectively. See full prescribing information for CLARINEX. CLARINEX® (desloratadine) Tablets, RediTabs®, and Oral Solution ...
Etodolac - American Academy of Veterinary Pharmacology and
Etodolac - American Academy of Veterinary Pharmacology and

... maintaining normal gastrointestinal and renal function in mammals while COX-2 produces prostaglandins involved in inflammation.{R-1} Although in vitro studies of human enzymes show etodolac selectively inhibiting COX-2 over COX-1, one in vitro experiment using canine cells demonstrated a fairly equa ...
CARDIAC TOXICITY OF CANCER THERAPEUTIC AGENTS
CARDIAC TOXICITY OF CANCER THERAPEUTIC AGENTS

... solid tumors (breast, SCLC) . • Acute toxicity : arrhythmias, LV dysfunction, and ...
studies on formulation and evaluation of floating tablet
studies on formulation and evaluation of floating tablet

... affecting Gastric emptying are 1)Volume of meal 2)composition of meal 3)viscosity of meal 4)Temperature of meal 5)Body posture 6)drug interaction 7)Disease state. The small intestinal transit time is an important parameter for drugs that are incompletely absorbed. Gastro retentive systems can remain ...
Newsletter
Newsletter

... the trial design is that at drug regulator, the the end of the dosing US Food and Drug Administration (FDA), and period, patients who exhibit a sub-response to providing the company with a vital foothold in the Lucentis® monotherapy will be offered OPT-302 world’s largest medical market – a market w ...
1222   Cardiovascular Drugs
1222 Cardiovascular Drugs

... Benazepril owes its activity to benazeprilat to which it is converted after oral dosage. The haemodynamic effects are seen within 1 hour of a single oral dose and the maximum effect occurs after about 2 to 4 hours, although the full effect may not develop for 1 to 2 weeks during chronic dosing. The ...
VIEW PDF
VIEW PDF

... the trial design is that at drug regulator, the the end of the dosing US Food and Drug Administration (FDA), and period, patients who exhibit a sub-response to providing the company with a vital foothold in the Lucentis® monotherapy will be offered OPT-302 world’s largest medical market – a market w ...
Sample Size Re-estimation Based on the Observed Treatment Effect
Sample Size Re-estimation Based on the Observed Treatment Effect

... “data driven adjustments” that compromise the overall study results. • Such “adjustments” can be more influential (and problematic) in NI trials where biases tend to make treatments appear more similar. • ADs can increase opportunities for such “adjustments” due to the increased flexibility and redu ...
Ocular Pharmacology
Ocular Pharmacology

... o Prostaglandin Analogues  Travaprost, latanoprost, unoprostone, bimatoprost  Prodrug is enzymatically hydrolyzed during its passage through the corneal epithelilum and the active form is released in the anterior chamber  Cats have different receptors and are not able to metabolize these drugs li ...


... Each patient was given a single 1-g dose of clarithromycin. One patient who had multiple recurrent episodes of erythrasma was also instructed to wash with dilute chlorhexidine gluconate solutions twice daily. Two weeks later the results of an examination using Wood light were negative in each patien ...
Fundamentals of Drug Testing
Fundamentals of Drug Testing

... Do not usually detect use within the past week.  Require a sample of hair about the diameter of a pencil and 1.5 inches  long. They can not be done with a single hair.  Test positive a little more than twice as often as a urine test.  Are not significantly affected by brief periods of abstinence fro ...
eTable 1. Study inclusion and exclusion criteria Inclusion criteria
eTable 1. Study inclusion and exclusion criteria Inclusion criteria

...  Subjects who currently meet the criteria for diagnosis of moderate or severe substance use disorder, by DSM-5 criteria,1 for any substances other than opioids, caffeine2, or nicotine  Subjects with uncontrolled medical or psychiatric illness or any clinically significant finding/abnormality in pa ...
INDEX S.No Categories 1 Applications for Investigational New
INDEX S.No Categories 1 Applications for Investigational New

... (Carcinogenicity studies should be performed for all drugs that are expected to be clinically used for more than 6 months as well as for drugs used frequently in an intermittent manner in the treatment of chronic or recurrent conditions. However, completed rodent carcinogenicity studies are not need ...
< 1 ... 356 357 358 359 360 361 362 363 364 ... 532 >

Theralizumab

  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report